2023 Inova Pulmonary Hypertension Day

November 3, 2023

The field of pulmonary hypertension (PH) has evolved substantially over the years. Updated guidelines on pathogenesis, diagnosis, phenotyping, and management of pulmonary hypertension were recently published. Inova Fairfax hospital houses the largest pulmonary hypertension in the Washington DC/Northern Virginia area, including the only chronic thromboembolic pulmonary hypertension center in the area. This course aims to help increase awareness of the disease and educate clinical staff about the newest updates in the field of PH. The course also offers a hands-on session for several devices used in management of pulmonary hypertension, including intravenous and subcutaneous pumps and various inhalation devices.

Target Audience

The content of this activity is applicable to healthcare providers in these specialties:

  • Cardiology

  • Pulmonary Disease

  • Thoracic Surgery

Learning Objectives

At the completion of this activity, learners should be able to:

  • Discuss the pathogenesis and phenotyping of pulmonary hypertension.

  • Enhance skills in identification and screening for pulmonary hypertension.

  • Recognize timely referral and management options for pulmonary hypertension.

  • Demonstrate knowledge and understanding of devices employed in the treatment of pulmonary hypertension.

 

Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
Course opens: 
11/03/2023
Course expires: 
02/03/2024
Event starts: 
11/03/2023 - 8:00am EDT
Event ends: 
11/03/2023 - 3:00pm EDT
Cost:
$0.00
Add to calendar: 
Rating: 
5

PDF icon PH day Agenda 2023.pdf

Disclosure Policy:

Inova Health System’s Office of Continuing Medical Education adheres to ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, program directors, and planners are required to disclose all relevant financial relationships with ineligible entities as defined by ACCME.  All relevant financial relationships listed for these individuals have been mitigated. 

Program Director(s)

Oksana Shlobin, MD, FCCP

has a financial relationship (Consulting Fee) with Bayer;.
has a financial relationship (Consulting Fee) with Janssen;.
has a financial relationship (Consulting Fee) with United Therapeutics;.
Speaker(s)

Johanna Coughlin, RN, BSN

has no relevant financial relationships to disclose at this time.

Susan Farrell, RRT, RPFT, AE-C, EP-C

has no relevant financial relationships to disclose at this time.

Michelle Gannon, PharmD, BCCP

has no relevant financial relationships to disclose at this time.

Raghav Gattani, MD

has no relevant financial relationships to disclose at this time.

Patricia Jackson, RN, BSN

has a financial relationship (Professional Services) with United Therapeutics;.

Jamie Kennedy, MD

has no relevant financial relationships to disclose at this time.

Vikramjit Khangoora, MD

has no relevant financial relationships to disclose at this time.

Christopher King, MD

has a financial relationship (Consulting Fee) with United Therapeutics;.
has a financial relationship (Consulting Fee) with Altavant;.
has a financial relationship (Consulting Fee) with Merck;.

Anastasia Maczko, RDN, CCTD

has no relevant financial relationships to disclose at this time.

Steven Nathan

has a financial relationship (Consulting Fee) with United Therapeutics;.
has a financial relationship (Consulting Fee) with Roivant;.
has a financial relationship (Consulting Fee) with Boehringer-Ingelheim;.
has a financial relationship (Consulting Fee) with Trevi Therapeutics;.
has a financial relationship (Consulting Fee) with Daewoong;.
has a financial relationship (Consulting Fee) with Merck;.

Christopher Thomas, MD

has no relevant financial relationships to disclose at this time.

Justin Van klein, MD

has no relevant financial relationships to disclose at this time.

Accreditation Statement:
The Inova Office Continuing Medical Education is accredited by the Medical Society of Virginia to sponsor continuing education for physicians.
 
Credit Designation:
The Inova Office of Continuing Medical Education designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 6.0 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.

 

Available Credit

  • 6.00 AMA PRA Category 1 Credit™

We thank these exhibitors for their support and participation:

  • Bayer
  • United Therapeutics
  • Liquidia
  • Enzyvant
  • Merck
  • Aerami
  • Aerovate
  • Accredo
  • Janssen
  • CVS specialty
  • Enzyvant

Price

Cost:
$0.00
Please login or register to take this course.